The company aims to find a combination target in the life sciences space and will be led by Kevin Rakin as Chairman and CEO and Matt Zuga, as CFO, COO and Director.
Total SPAC deal count for 2020 year-to-date is now 85 with $33.978 billion in gross proceeds raised. This offering is expected to close on Wednesday, September 9, 2020.
Cantor Fitzgerald & Co. is acting as the sole bookrunner for the offering. White & Case LLP serve as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC, serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.